MOG and myeloid sarcoma: However, a number of subsequent studies conducted with similar testing assays using denaturated MOG proteins (e.g., ELISA) showed that MOG-IgG was not disease-specific, being detectable with similar frequency in patients with MS, other demyelinating CNS disorders, and unaffected controls (14, 15).